12/02/2024
DEA to Hold Hearing on the Rescheduling of Ma*****na today
9:30 a.m. to 5 p.m.
On May 21, 2024, the Department of Justice proposed to transfer ma*****na from schedule I of the Controlled Substances Act to schedule III of the CSA, consistent with the view of the Department of Health and Human Services that ma*****na has a currently accepted medical use as well as HHS's views about ma*****na's abuse potential and level of physical or psychological dependence.
The CSA requires that such actions be made through formal rulemaking on the record after opportunity for a hearing. If the transfer to schedule III is finalized, the regulatory controls applicable to schedule III controlled substances would apply, as appropriate, along with existing ma*****na-specific requirements and any additional controls that might be implemented, including those that might be implemented to meet U.S. treaty obligations. If ma*****na is transferred into schedule III, the manufacture, distribution, dispensing, and possession of ma*****na would remain subject to the applicable criminal prohibitions of the CSA.
Any drugs containing a substance within the CSA's definition of “ma*****na” would also remain subject to the applicable prohibitions in the Federal Food, Drug, and Cosmetic Act.
Watch the hearing LIVE by clicking the link below
